Seventure Partners

French startup lands $8.7M to advance microbiome therapies

Founded in 2014, MaaT Pharma is pushing two therapies through clinical trials that are designed improve survival for patients with blood cancers and other diseases. Despite high-profile hiccups, the field of microbiome therapy remains attractive to investors.

By Joel Berg

BioPharma, Startups

Vedanta Biosciences raises $27M in Series C round

The company plans to use the funding to support its various microbiome-based drug development programs in oncology, food allergy and bacterial infection.

By Alaric DeArment

With the Rise of AI, What IP Disputes in Healthcare Are Likely to Emerge?

Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.

A Personalized Approach to Medication Nonadherence

At the Abarca Forward conference earlier this year, George Van Antwerp, managing director at Deloitte, discussed how social determinants of health and a personalized member experience can improve medication adherence and health outcomes.

French startup lands $8.7M to advance microbiome therapies

Vedanta Biosciences raises $27M in Series C round

When Investment Rhymes with Canada